Rehabilitation With and Without Robot and Allied Digital Technologies in Stroke Patients
NCT ID: NCT06547827
Last Updated: 2025-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
596 participants
INTERVENTIONAL
2024-08-12
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This multicentre randomized controlled pragmatic trial aims at comprehensively and accurately assessing the effectiveness of rehabilitation mediated by RADTs after a stroke, compared to traditional rehabilitation, also considering economic sustainability.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-segmental Robotic and Technological Upper Limb Rehabilitation in Stroke
NCT02879279
Innovative Models in the Rehabilitation of the Elderly With Stroke Through Technological Innovation
NCT04087083
The Effects of Gait Rehabilitation After Stroke by Treadmill-based Robotics Versus Traditional Gait Training
NCT03688165
Robotic Rehabilitation and Cognitive Functions
NCT04164381
Robot Walking Rehabilitation in Stroke Patients
NCT01678547
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary Objective: To demonstrate, in a population of subacute stroke patients, the non-inferiority of a rehabilitation treatment integrated with robotic and/or technological devices compared to traditional rehabilitative treatment in the recovery of activities of daily living.
Secondary Objectives:
* To demonstrate the superiority of rehabilitative treatment integrated with robotic and/or technological devices compared to traditional rehabilitation treatment in the recovery of activities of daily living, should non-inferiority be demonstrated;
* To compare the improvements between two groups in all targeted domains (upper limb sensorimotor abilities; lower limb sensorimotor abilities and gait; balance; cognitive abilities), in accordance with the International Classification of Functioning, Disability, and Health (ICF);
* To analyze the neurophysiological parameters and factors involved in neuroplasticity processes;
* To compare the time pattern of manual dexterity and walking performance recovery in the two groups;
* To assess the effects of the rehabilitation treatment in terms of daily life activities and quality of life through medium-term follow-up;
* To evaluate the acceptability and usability of the rehabilitative treatment integrated with robotic and/or technological devices for the patient, their family, and the healthcare practitioner;
* To create a predictive model capable of forecasting the effectiveness of robotic and technological treatment in subjects after a stroke, based on a detailed description of the patient at baseline (using demographic data and clinical picture at admission);
* To assess the economic sustainability of the rehabilitative treatment integrated with robotic and/or technological devices for the patient, payer, and society, through the creation of a model for the assessment and prediction of cost-effectiveness, cost-utility, and, for the healthcare system, a Budget Impact Analysis, and related sensitivity analyses.
The study employs a multicenter, multimodal, randomized, controlled, parallel-group (1:1) interventional design with blinded assessors, following a pragmatic approach. It will be conducted across multiple clinical centers involved in a national research initiative, encompassing both outpatient and inpatient settings. Randomization will be centralized and stratified by clinical center, latency, and clinical setting (inpatients or outpatients).
The sample size (596 patients) was determined considering the following, with respect to the primary outcome (the change in the modified Barthel Index): (a) the non-inferiority of robotic treatment compared to traditional treatment; (b) a power of 80%; (c) a non-inferiority margin of 5 points; (d) a bilateral 95% confidence interval; (e) a standard deviation of the primary outcome of 20 points. Considering these parameters, a sample size of 506 patients (253 per group) is obtained. Additionally, considering a dropout rate of 15%, a total sample size of 596 patients is obtained. The same sample size is sufficient to also demonstrate the potential superiority of robotic treatment. In fact, considering a significance level of 5%, a power of 80%, a minimal clinically important difference of the scale of 9.25 points, a standard deviation of 20 points, and a dropout rate of 15%, a total of 178 patients are required for demonstrating superiority.
The experimental group will receive rehabilitation using RADTs within a new organizational model, where two physical therapists supervise four to six patients. In the control group, patients will undergo individual traditional rehabilitation, maintaining a 1:1 patient-to-therapist ratio. In both groups, patients will undergo comprehensive rehabilitation treatment, targeting the following domains: a) upper limb sensorimotor abilities; b) lower limb sensorimotor abilities and gait; c) balance; d) cognitive abilities.
The primary outcome is to demonstrate non-inferiority in activities of daily living as measured by the modified Barthel Index. Should non-inferiority be established, the study will then evaluate the potential superiority of RADTs in activities of daily living.
All participating centers will follow a standardized operating procedure regarding treatment and outcome assessment to ensure consistency across all sites. Data will be systematically collected using the REDCap (Research Electronic Data Capture) platform.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Integrated Treatment with Robotic & Technological Devices (RADTs)
This intervention employs various RADTs to target the following domains: a) upper limb sensorimotor abilities; b) lower limb sensorimotor abilities and gait; c) balance; and d) cognitive abilities. For upper limb sensorimotor function, we will use planar end-effector robots, exoskeletons, or electromechanical systems for shoulder, elbow, and wrist rehabilitation; end-effector robots or exoskeletons for hand rehabilitation; and sensor-based devices for comprehensive upper limb treatment. For lower limb sensorimotor function, we will utilize end-effector robots or exoskeletons and treadmills with body-weight support systems. Balance training will involve stabilometric platforms and sensor-based systems. Cognitive functions will be addressed using digital systems, sensor-based devices, and virtual reality programs. All devices must have a CE mark for medical devices and be used according to the manufacturer's specifications.
robotic rehabilitation
Treatment will occur in a gym equipped with devices for all the domains, with two physiotherapists supervising groups of 4 to 6 patients, depending on their clinical severity.
Patients will undergo a total of 25 sessions, each lasting 45 minutes, with the following frequency:
* 5 times a week for 5 weeks, for inpatients;
* 3 times a week for 8.3 weeks, for outpatients.
Traditional Treatment
In the control group, subjects will undergo a standard traditional rehabilitation program without the use of RADTs, focusing on the following domains:a) upper limb sensorimotor abilities; b) lower limb sensorimotor abilities and gait; c) balance; and d) cognitive abilities, using traditional methods of physiotherapy and cognitive rehabilitation.
traditional rehabilitation
A physiotherapist-to-patient ratio of 1:1 is provided for the treatment in all participating centres.
Patients will undergo a total of 25 sessions, each lasting 45 minutes, with the following frequency:
* 5 times a week for 5 weeks, for inpatients;
* 3 times a week for 8.3 weeks, for outpatients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
robotic rehabilitation
Treatment will occur in a gym equipped with devices for all the domains, with two physiotherapists supervising groups of 4 to 6 patients, depending on their clinical severity.
Patients will undergo a total of 25 sessions, each lasting 45 minutes, with the following frequency:
* 5 times a week for 5 weeks, for inpatients;
* 3 times a week for 8.3 weeks, for outpatients.
traditional rehabilitation
A physiotherapist-to-patient ratio of 1:1 is provided for the treatment in all participating centres.
Patients will undergo a total of 25 sessions, each lasting 45 minutes, with the following frequency:
* 5 times a week for 5 weeks, for inpatients;
* 3 times a week for 8.3 weeks, for outpatients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 years and over;
* Time since the event equal to or less than 6 months;
* Mild to severe impairment of the upper limb (motor section of the Fugl-Meyer Assessment of Upper Extremity ≤ 58) and/or mild to severe impairment of the lower limb (score on the Functional Ambulation Categories scale ≤ 4) and/or mild to severe impairment of balance (Berg Balance Scale ≤ 45);
* Clinical stability allowing transfer to the gym and execution of the planned treatments.
Exclusion Criteria
* Behavioral/cognitive disorders preventing adequate patient compliance with both traditional and robotic rehabilitation treatment (severe cognitive deficit, Montreal Cognitive Assessment \<10);
* Rigidity or hypertonia (Modified Ashworth Scale \> 3) in the plegic/paretic limb;
* Serious uncorrectable visual impairments preventing the patient from performing treatment with technological and/or robotic devices;
* Pregnant women;
* Refusal to sign the informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituti Clinici Scientifici Maugeri SpA
OTHER
IRCCS National Neurological Institute "C. Mondino" Foundation
OTHER
Ospedale Policlinico San Martino
OTHER
Università di Pavia
UNKNOWN
Scuola Superiore Sant'Anna di Pisa
OTHER
Fondazione Don Carlo Gnocchi Onlus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Irene G Aprile
Role: STUDY_DIRECTOR
IRCCS Fondazione Don Carlo Gnocchi
Irene G Aprile
Role: PRINCIPAL_INVESTIGATOR
IRCCS Fondazione Don Carlo Gnocchi
Christian Lunetta
Role: PRINCIPAL_INVESTIGATOR
IRCCS Istituti Clinici Scientifici Maugeri
Roberto De Icco
Role: PRINCIPAL_INVESTIGATOR
IRCCS Fondazione Mondino
Carlo Trompetto
Role: PRINCIPAL_INVESTIGATOR
IRCCS Ospedale Policlinico San Martino
Silvana Quaglini
Role: PRINCIPAL_INVESTIGATOR
Università di Pavia
Giuseppe Turchetti
Role: PRINCIPAL_INVESTIGATOR
Scuola Superiore Sant'Anna di Pisa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Don Carlo Gnocchi, Centro Gala
Acerenza, , Italy
IRCCS Istituti Clinici Scientifici Maugeri
Bari, , Italy
IRCCS Ospedale Policlinico San Martino,
Genova, , Italy
Fondazione Don Carlo Gnocchi, IRCCS Santa Maria Nascente
Milan, , Italy
IRCCS Istituti Clinici Scientifici Maugeri
Milan, , Italy
IRCCS Istituti Clinici Scientifici Maugeri
Montescano, , Italy
IRCCS Fondazione Mondino
Pavia, , Italy
IRCCS Istituti Clinici Scientifici Maugeri
Pavia, , Italy
Fondazione Don Carlo Gnocchi, Centro Santa Maria della Provvidenza
Roma, , Italy
Fondazione Don Carlo Gnocchi, Centro Santa Maria al Mare
Salerno, , Italy
Fondazione Don Carlo Gnocchi, Polo Specialistico Riabilitativo
Sant'Angelo dei Lombardi, , Italy
IRCCS Istituti Clinici Scientifici Maugeri
Telese Terme, , Italy
Fondazione Don Carlo Gnocchi, Polo specialistico riabilitativo
Tricarico, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rocco Santarsiero
Role: primary
Pietro Fiore
Role: primary
Trompetto Carlo
Role: primary
Jorge Navarro
Role: primary
Christian Lunetta
Role: primary
Cira Fundarò
Role: primary
Roberto De Icco
Role: primary
Antonio Nardone
Role: primary
Domiziano Tarantino
Role: primary
Tommaso Cibellis
Role: primary
Laura Marcuccio
Role: primary
Massimo Tolve
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Aprile IG, Germanotta M, Fasano A, Siotto M, Mauro MC, Pavan A, Nicora G, Sgandurra G, Malovini A, Oreni L, Dubbini N, Parimbelli E, Comande G, Lunetta C, Fiore P, De Icco R, Trompetto C, Trieste L, Turchetti G, Quaglini S, Messa C; STROKEFIT4 Study Group. Rehabilitation with and Without Robot and Allied Digital Technologies (RADTs) in Stroke Patients: A Study Protocol for a Multicentre Randomised Controlled Trial on the Effectiveness, Acceptability, Usability, and Economic-Organisational Sustainability of RADTs from Subacute to Chronic Phase (STROKEFIT4). J Clin Med. 2025 Apr 15;14(8):2692. doi: 10.3390/jcm14082692.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PNC0000007
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
FIT4MedRobStroke
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.